NVAX Novavax, Inc.
NVAX Novavax, Inc.
Healthcare · Biotechnology
Market read
POC $9.35 · VWAP $9.26 · +4.8% vs 12m avg buyer
Insiders quiet 0 buy / 0 sell · Form 4, 90d
Coverage
1 watchlist
NVAX Price Structure
Loading timeframes…
Peers
Every watchlist NVAX belongs to, members best 30-day change first — NVAX highlighted in place. Each pill: 30d change, 1d/7d, and a close spark over the last 30 calendar days (~21 sessions); hover for price, RSI, and the full chart.
@monster-discoveries
Against street estimates
How NVAX's reported EPS compared with analyst consensus. Street estimates are single-source vendor consensus (yfinance). Actuals are vendor consensus-basis EPS (often non-GAAP); edgarEps is GAAP diluted from filings — disputed flags large disagreement only. A consensus out of line with the name's earlier estimates (opposite sign to all of them and over 3x their size) is not graded. EPS only.
Recent news
Headlines about NVAX from the desk's news pull — links go to the publisher. Not a desk read: the market read above is the desk's own.
pulled 4 days ago · Oct 19
- Markets & Stocks - Novavax, Inc. - Common Stock (Nasdaq:NVAX) Stock Quote
- User | thepilotnews.com - Novavax, Inc. - Common Stock (Nasdaq:NVAX) Stock Quote
- Novavax, Inc. - Common Stock (Nasdaq:NVAX) Stock Quote
- NVAX - Novavax Inc Earnings Reports, Summaries & Call Transcripts | Morningstar
- Novavax Reports Second Quarter 2026 Financial Results and Operational Highlights
NVAX research tape
10 dated scans, research, and events, newest first — the full record. Desk commentary and scheduled prints sit in their own panes.